Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Skeletal | 11 | 2022 | 4969 | 1.190 |
Why?
|
Burns | 10 | 2018 | 1788 | 0.970 |
Why?
|
Regeneration | 4 | 2020 | 1544 | 0.910 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 41 | 0.830 |
Why?
|
Muscle Development | 6 | 2020 | 308 | 0.820 |
Why?
|
Mastectomy | 3 | 2017 | 1680 | 0.790 |
Why?
|
Skin Transplantation | 5 | 2018 | 1130 | 0.780 |
Why?
|
Mammaplasty | 5 | 2017 | 1126 | 0.770 |
Why?
|
Surgical Wound Infection | 3 | 2018 | 1490 | 0.750 |
Why?
|
Guided Tissue Regeneration | 1 | 2019 | 94 | 0.730 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2006 | 1179 | 0.720 |
Why?
|
Tissue Scaffolds | 4 | 2022 | 946 | 0.710 |
Why?
|
Occlusive Dressings | 1 | 2018 | 54 | 0.700 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 127 | 0.700 |
Why?
|
Sarcopenia | 2 | 2021 | 304 | 0.700 |
Why?
|
Breast Implantation | 2 | 2017 | 214 | 0.650 |
Why?
|
Chitosan | 1 | 2018 | 143 | 0.640 |
Why?
|
Surgical Flaps | 6 | 2018 | 1630 | 0.640 |
Why?
|
Matrix Metalloproteinase 9 | 7 | 2006 | 696 | 0.600 |
Why?
|
Contracture | 2 | 2016 | 211 | 0.580 |
Why?
|
Matrix Metalloproteinase 2 | 4 | 2006 | 474 | 0.550 |
Why?
|
Wound Healing | 5 | 2021 | 2800 | 0.540 |
Why?
|
Parabiosis | 1 | 2014 | 63 | 0.530 |
Why?
|
Facial Transplantation | 4 | 2021 | 218 | 0.530 |
Why?
|
Muscular Diseases | 1 | 2017 | 555 | 0.470 |
Why?
|
Pancreatic Elastase | 6 | 2006 | 153 | 0.460 |
Why?
|
Fibrosis | 3 | 2018 | 1947 | 0.440 |
Why?
|
Cartoons as Topic | 1 | 2011 | 17 | 0.440 |
Why?
|
Osteosarcoma | 1 | 2016 | 891 | 0.390 |
Why?
|
Recovery of Function | 2 | 2019 | 2950 | 0.360 |
Why?
|
Cell Cycle | 1 | 2016 | 3014 | 0.320 |
Why?
|
Child Welfare | 1 | 2011 | 512 | 0.310 |
Why?
|
Muscle Fibers, Skeletal | 5 | 2018 | 569 | 0.300 |
Why?
|
Breast | 1 | 2015 | 1782 | 0.300 |
Why?
|
Nitroso Compounds | 1 | 2006 | 68 | 0.300 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 126 | 0.290 |
Why?
|
Aging | 4 | 2021 | 8358 | 0.290 |
Why?
|
Testosterone | 2 | 2014 | 2352 | 0.290 |
Why?
|
Facial Injuries | 2 | 2017 | 189 | 0.290 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9556 | 0.280 |
Why?
|
Muscle Strength | 2 | 2019 | 570 | 0.260 |
Why?
|
Health Education | 1 | 2011 | 1062 | 0.260 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 607 | 0.260 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2006 | 1268 | 0.250 |
Why?
|
Adipose Tissue | 1 | 2016 | 3234 | 0.250 |
Why?
|
Cell Movement | 4 | 2018 | 5489 | 0.240 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2579 | 0.240 |
Why?
|
Cell Proliferation | 2 | 2017 | 10803 | 0.240 |
Why?
|
Organ Size | 3 | 2019 | 2317 | 0.230 |
Why?
|
Metalloendopeptidases | 1 | 2004 | 420 | 0.230 |
Why?
|
Surgery, Plastic | 3 | 2016 | 562 | 0.230 |
Why?
|
India | 5 | 2016 | 1967 | 0.220 |
Why?
|
Animals | 31 | 2021 | 170486 | 0.220 |
Why?
|
Estrogen Receptor beta | 1 | 2022 | 171 | 0.210 |
Why?
|
Tissue Engineering | 3 | 2022 | 1852 | 0.210 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2006 | 621 | 0.190 |
Why?
|
Wounds and Injuries | 3 | 2021 | 2408 | 0.190 |
Why?
|
Rats, Sprague-Dawley | 8 | 2006 | 8593 | 0.180 |
Why?
|
Neuromuscular Junction | 1 | 2021 | 359 | 0.180 |
Why?
|
Skin Pigmentation | 1 | 2021 | 279 | 0.180 |
Why?
|
Breast Neoplasms | 6 | 2022 | 19800 | 0.180 |
Why?
|
Mice | 16 | 2021 | 80876 | 0.180 |
Why?
|
Health Promotion | 1 | 2011 | 2172 | 0.180 |
Why?
|
Ischemic Preconditioning | 1 | 2018 | 88 | 0.170 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 567 | 0.170 |
Why?
|
Leukocytes | 1 | 2006 | 2095 | 0.170 |
Why?
|
Replantation | 1 | 2018 | 149 | 0.160 |
Why?
|
Glycosaminoglycans | 1 | 2019 | 601 | 0.150 |
Why?
|
Rats | 10 | 2018 | 25094 | 0.150 |
Why?
|
Thyroid Hormone Receptors alpha | 1 | 2016 | 12 | 0.150 |
Why?
|
Fetus | 2 | 2014 | 1828 | 0.150 |
Why?
|
Organ Preservation | 1 | 2018 | 274 | 0.150 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 22989 | 0.150 |
Why?
|
Pentylenetetrazole | 1 | 2016 | 67 | 0.150 |
Why?
|
Keratinocytes | 2 | 2018 | 797 | 0.150 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2016 | 63 | 0.150 |
Why?
|
Sex Characteristics | 1 | 2006 | 2510 | 0.150 |
Why?
|
Nutritional Requirements | 1 | 2017 | 289 | 0.140 |
Why?
|
Satellite Cells, Skeletal Muscle | 1 | 2016 | 125 | 0.140 |
Why?
|
Oxidative Stress | 1 | 2006 | 3156 | 0.140 |
Why?
|
Transplantation, Homologous | 4 | 2021 | 4831 | 0.140 |
Why?
|
rho-Associated Kinases | 1 | 2016 | 277 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2021 | 3490 | 0.140 |
Why?
|
Hypertrophy | 2 | 2014 | 579 | 0.130 |
Why?
|
Aorta, Abdominal | 3 | 2006 | 705 | 0.130 |
Why?
|
Disease Models, Animal | 7 | 2018 | 18375 | 0.130 |
Why?
|
Breast Implants | 1 | 2017 | 356 | 0.130 |
Why?
|
Transplantation, Autologous | 2 | 2018 | 2092 | 0.130 |
Why?
|
Graft Survival | 4 | 2018 | 3767 | 0.130 |
Why?
|
Time Factors | 6 | 2018 | 41038 | 0.130 |
Why?
|
Diseases in Twins | 1 | 2015 | 459 | 0.120 |
Why?
|
Wrist Injuries | 1 | 2015 | 194 | 0.120 |
Why?
|
Thyroid Hormones | 1 | 2016 | 378 | 0.120 |
Why?
|
Neutrophil Infiltration | 2 | 2006 | 407 | 0.120 |
Why?
|
Hand Injuries | 1 | 2015 | 235 | 0.120 |
Why?
|
Bronchodilator Agents | 1 | 2016 | 512 | 0.120 |
Why?
|
Kerosene | 1 | 2012 | 14 | 0.120 |
Why?
|
Extremities | 1 | 2018 | 875 | 0.120 |
Why?
|
Apoptosis | 3 | 2022 | 10085 | 0.110 |
Why?
|
Graft Rejection | 3 | 2021 | 4408 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1040 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 541 | 0.110 |
Why?
|
West Virginia | 1 | 2011 | 25 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 12447 | 0.110 |
Why?
|
Enteral Nutrition | 1 | 2017 | 725 | 0.110 |
Why?
|
Mitochondria | 1 | 2005 | 3665 | 0.110 |
Why?
|
Enzyme Activation | 3 | 2009 | 3879 | 0.110 |
Why?
|
Thoracic Wall | 1 | 2013 | 193 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2020 | 1423 | 0.110 |
Why?
|
Cells, Cultured | 9 | 2018 | 20170 | 0.110 |
Why?
|
Cytokines | 1 | 2006 | 7189 | 0.110 |
Why?
|
Postoperative Care | 1 | 2018 | 1514 | 0.110 |
Why?
|
Gene Expression | 3 | 2021 | 8014 | 0.100 |
Why?
|
Male | 23 | 2021 | 349524 | 0.100 |
Why?
|
Perfusion | 3 | 2018 | 1272 | 0.100 |
Why?
|
Collagen | 1 | 2019 | 2687 | 0.100 |
Why?
|
Hypothyroidism | 1 | 2016 | 650 | 0.100 |
Why?
|
Alternative Splicing | 1 | 2016 | 1123 | 0.100 |
Why?
|
Humans | 37 | 2022 | 708843 | 0.100 |
Why?
|
Rectus Abdominis | 1 | 2010 | 98 | 0.100 |
Why?
|
Female | 23 | 2022 | 375205 | 0.100 |
Why?
|
Stem Cells | 2 | 2014 | 3593 | 0.100 |
Why?
|
Workload | 1 | 2016 | 852 | 0.100 |
Why?
|
Irritants | 1 | 2009 | 42 | 0.100 |
Why?
|
Osteogenesis | 2 | 2014 | 1283 | 0.100 |
Why?
|
Fibroblasts | 2 | 2018 | 4299 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2018 | 3021 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2593 | 0.090 |
Why?
|
Dioxoles | 1 | 2009 | 112 | 0.090 |
Why?
|
Tetrahydroisoquinolines | 1 | 2009 | 100 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2014 | 759 | 0.090 |
Why?
|
Perioperative Care | 1 | 2017 | 1067 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 2032 | 0.090 |
Why?
|
Myostatin | 1 | 2009 | 125 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2006 | 1632 | 0.090 |
Why?
|
Skin Ulcer | 1 | 2009 | 126 | 0.090 |
Why?
|
Embryonic Stem Cells | 1 | 2016 | 1386 | 0.090 |
Why?
|
Memory Disorders | 1 | 2016 | 1139 | 0.090 |
Why?
|
Cell Line | 2 | 2020 | 16657 | 0.090 |
Why?
|
Pilot Projects | 2 | 2018 | 7994 | 0.080 |
Why?
|
Earthquakes | 1 | 2010 | 174 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2563 | 0.080 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 179 | 0.080 |
Why?
|
Patient Preference | 1 | 2015 | 856 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 469 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 1572 | 0.080 |
Why?
|
Child, Preschool | 6 | 2020 | 41081 | 0.080 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1641 | 0.080 |
Why?
|
Reading | 1 | 2011 | 546 | 0.080 |
Why?
|
Cyclic N-Oxides | 1 | 2006 | 78 | 0.080 |
Why?
|
Signal Transduction | 4 | 2020 | 23950 | 0.080 |
Why?
|
International Cooperation | 2 | 2011 | 1434 | 0.080 |
Why?
|
Treatment Outcome | 8 | 2018 | 61932 | 0.080 |
Why?
|
Immunohistochemistry | 5 | 2014 | 11790 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2020 | 11718 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2015 | 871 | 0.080 |
Why?
|
Burn Units | 2 | 2017 | 131 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1756 | 0.070 |
Why?
|
Caspase 9 | 1 | 2005 | 197 | 0.070 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 455 | 0.070 |
Why?
|
Reconstructive Surgical Procedures | 3 | 2015 | 2137 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1746 | 0.070 |
Why?
|
African Americans | 1 | 2021 | 5118 | 0.070 |
Why?
|
Spin Labels | 1 | 2006 | 323 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2022 | 4065 | 0.070 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2004 | 18 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2016 | 2968 | 0.070 |
Why?
|
Developing Countries | 3 | 2012 | 2674 | 0.070 |
Why?
|
Disasters | 1 | 2010 | 485 | 0.070 |
Why?
|
Catalase | 1 | 2005 | 239 | 0.070 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2005 | 130 | 0.070 |
Why?
|
Dilatation, Pathologic | 1 | 2006 | 517 | 0.070 |
Why?
|
Logistic Models | 2 | 2017 | 13468 | 0.070 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 861 | 0.060 |
Why?
|
P-Selectin | 1 | 2006 | 611 | 0.060 |
Why?
|
Adolescent | 6 | 2020 | 84718 | 0.060 |
Why?
|
Adult | 10 | 2018 | 211041 | 0.060 |
Why?
|
Young Adult | 5 | 2017 | 55940 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8638 | 0.060 |
Why?
|
Patient Satisfaction | 3 | 2013 | 3376 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2006 | 13314 | 0.060 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 735 | 0.060 |
Why?
|
Caspase 3 | 1 | 2005 | 805 | 0.060 |
Why?
|
Reoperation | 3 | 2021 | 4159 | 0.060 |
Why?
|
Child | 6 | 2020 | 73636 | 0.060 |
Why?
|
Schools | 1 | 2011 | 1361 | 0.060 |
Why?
|
Caspases | 1 | 2005 | 940 | 0.060 |
Why?
|
Fat Necrosis | 2 | 2013 | 61 | 0.060 |
Why?
|
Drug Implants | 2 | 2018 | 241 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2007 | 1210 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2006 | 681 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4099 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2881 | 0.050 |
Why?
|
Injury Severity Score | 2 | 2017 | 987 | 0.050 |
Why?
|
Students | 1 | 2011 | 1562 | 0.050 |
Why?
|
Adipogenesis | 2 | 2014 | 349 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2006 | 953 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2005 | 1151 | 0.050 |
Why?
|
Necrosis | 2 | 2018 | 1646 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39038 | 0.050 |
Why?
|
Neutropenia | 1 | 2005 | 871 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2007 | 3318 | 0.050 |
Why?
|
Aged | 6 | 2021 | 161488 | 0.050 |
Why?
|
Tamoxifen | 1 | 2005 | 989 | 0.050 |
Why?
|
Up-Regulation | 2 | 2006 | 4353 | 0.050 |
Why?
|
Inflammation | 2 | 2018 | 10019 | 0.050 |
Why?
|
Swine | 2 | 2021 | 5763 | 0.050 |
Why?
|
Postoperative Complications | 3 | 2011 | 15053 | 0.050 |
Why?
|
Middle Aged | 7 | 2018 | 213752 | 0.050 |
Why?
|
Registries | 1 | 2015 | 7989 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2021 | 775 | 0.050 |
Why?
|
Transfection | 2 | 2018 | 6161 | 0.040 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2021 | 286 | 0.040 |
Why?
|
Estrogens | 2 | 2022 | 1511 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1678 | 0.040 |
Why?
|
Ink | 1 | 2018 | 44 | 0.040 |
Why?
|
Neovascularization, Physiologic | 2 | 2021 | 1422 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 5850 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 3093 | 0.040 |
Why?
|
Mice, Obese | 1 | 2018 | 451 | 0.040 |
Why?
|
Suction | 1 | 2018 | 255 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2016 | 1712 | 0.040 |
Why?
|
Tissue Expansion | 1 | 2018 | 162 | 0.040 |
Why?
|
Sodium Salicylate | 1 | 2016 | 20 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 39292 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 28919 | 0.040 |
Why?
|
Skin Physiological Phenomena | 1 | 2018 | 183 | 0.040 |
Why?
|
Paracrine Communication | 1 | 2018 | 284 | 0.040 |
Why?
|
Anniversaries and Special Events | 1 | 2017 | 87 | 0.040 |
Why?
|
Biliopancreatic Diversion | 1 | 2015 | 11 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 10857 | 0.040 |
Why?
|
Internship and Residency | 1 | 2016 | 5556 | 0.040 |
Why?
|
France | 1 | 2017 | 459 | 0.040 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2016 | 103 | 0.040 |
Why?
|
Esthetics | 1 | 2017 | 304 | 0.040 |
Why?
|
Receptors, Steroid | 1 | 2016 | 153 | 0.040 |
Why?
|
Mice, Inbred Strains | 1 | 2018 | 1922 | 0.040 |
Why?
|
Platelet-Rich Plasma | 1 | 2018 | 174 | 0.040 |
Why?
|
Body Surface Area | 1 | 2015 | 204 | 0.040 |
Why?
|
CA1 Region, Hippocampal | 1 | 2016 | 115 | 0.030 |
Why?
|
Program Development | 2 | 2013 | 1328 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3297 | 0.030 |
Why?
|
Needs Assessment | 2 | 2012 | 1147 | 0.030 |
Why?
|
Cold Temperature | 1 | 2018 | 789 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3417 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1974 | 0.030 |
Why?
|
Infant | 4 | 2020 | 34261 | 0.030 |
Why?
|
Time | 1 | 2016 | 526 | 0.030 |
Why?
|
Stem Cell Transplantation | 2 | 2014 | 1660 | 0.030 |
Why?
|
PAX7 Transcription Factor | 1 | 2014 | 57 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2016 | 489 | 0.030 |
Why?
|
Cell Lineage | 2 | 2014 | 2630 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2016 | 380 | 0.030 |
Why?
|
Dendritic Spines | 1 | 2016 | 237 | 0.030 |
Why?
|
Macrophages | 2 | 2006 | 5784 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 569 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2016 | 297 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2014 | 101 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2018 | 2015 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2015 | 488 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1102 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2014 | 372 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2016 | 342 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1843 | 0.030 |
Why?
|
Pyramidal Cells | 1 | 2016 | 366 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58184 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 10040 | 0.030 |
Why?
|
Hydrogels | 1 | 2018 | 648 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9927 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1290 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 11239 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 6127 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2779 | 0.030 |
Why?
|
Efficiency | 1 | 2016 | 487 | 0.030 |
Why?
|
Cicatrix | 1 | 2018 | 689 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1246 | 0.030 |
Why?
|
Neutrophils | 1 | 2005 | 3867 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2017 | 2635 | 0.030 |
Why?
|
Neoplasms | 1 | 2020 | 20172 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4306 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1233 | 0.030 |
Why?
|
Work Schedule Tolerance | 1 | 2016 | 560 | 0.030 |
Why?
|
Homozygote | 1 | 2016 | 1849 | 0.030 |
Why?
|
Burns, Chemical | 1 | 2012 | 155 | 0.030 |
Why?
|
Epigastric Arteries | 1 | 2010 | 79 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1726 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2472 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 69553 | 0.020 |
Why?
|
Hernia, Abdominal | 1 | 2010 | 53 | 0.020 |
Why?
|
Donor Selection | 1 | 2011 | 188 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2680 | 0.020 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 107 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2016 | 1195 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2014 | 1908 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2017 | 71483 | 0.020 |
Why?
|
Haiti | 1 | 2010 | 544 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1357 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2459 | 0.020 |
Why?
|
Cell Separation | 1 | 2014 | 1835 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2006 | 21194 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2010 | 250 | 0.020 |
Why?
|
Leptin | 1 | 2015 | 1572 | 0.020 |
Why?
|
Risk Assessment | 3 | 2017 | 23284 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1712 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 20320 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1999 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 3026 | 0.020 |
Why?
|
Military Personnel | 1 | 2015 | 1050 | 0.020 |
Why?
|
Aorta | 2 | 2005 | 2120 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2016 | 15274 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 6156 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2244 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 24433 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3700 | 0.020 |
Why?
|
Glucose | 1 | 2018 | 4261 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 909 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6562 | 0.020 |
Why?
|
Cricetulus | 1 | 2007 | 857 | 0.020 |
Why?
|
Amitrole | 1 | 2005 | 8 | 0.020 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2005 | 67 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2014 | 2427 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16959 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 154 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 641 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2536 | 0.020 |
Why?
|
CHO Cells | 1 | 2007 | 1438 | 0.020 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 511 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 2473 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2303 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1829 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2945 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 6068 | 0.020 |
Why?
|
Skin | 1 | 2018 | 4325 | 0.020 |
Why?
|
Device Removal | 1 | 2009 | 656 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2010 | 987 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4226 | 0.020 |
Why?
|
Drainage | 1 | 2009 | 1131 | 0.020 |
Why?
|
Cricetinae | 1 | 2007 | 2588 | 0.020 |
Why?
|
Echocardiography | 1 | 2016 | 5139 | 0.020 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2005 | 255 | 0.020 |
Why?
|
Lymphocyte Depletion | 1 | 2005 | 638 | 0.020 |
Why?
|
Physician's Role | 1 | 2010 | 982 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9402 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4169 | 0.010 |
Why?
|
Dogs | 1 | 2007 | 4059 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2015 | 3418 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20308 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4592 | 0.010 |
Why?
|
Retinal Vessels | 1 | 2007 | 767 | 0.010 |
Why?
|
Low Back Pain | 1 | 2010 | 922 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6989 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6257 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3813 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2877 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 2059 | 0.010 |
Why?
|
Cost of Illness | 1 | 2011 | 1820 | 0.010 |
Why?
|
Sex Factors | 2 | 2005 | 10566 | 0.010 |
Why?
|
Cell Communication | 1 | 2007 | 1653 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 11594 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5405 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18712 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2011 | 1880 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16306 | 0.010 |
Why?
|
Health Policy | 1 | 2011 | 2615 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7644 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4941 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5456 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9639 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17218 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 26832 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2011 | 4988 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 12031 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2004 | 2937 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 50597 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 23020 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 16008 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29262 | 0.010 |
Why?
|